Mycophenolic Acid Trough Concentration and Dose Are Associated with Hematologic Abnormalities but Not Rejection in Kidney Transplant Recipients

BACKGROUND: Little is known regarding the safe fixed dose of mycophenolic acid (MPA) for preventing biopsy-proven acute rejection (BPAR) in kidney transplant recipients (KTRs). We investigated the correlation of MPA trough concentration (MPA C(0)) and dose with renal transplant outcomes and adverse...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Korean Med Sci
Главные авторы: Jung, Hee-Yeon, Lee, Sukyung, Jeon, Yena, Choi, Ji-Young, Cho, Jang-Hee, Park, Sun-Hee, Kim, Yong-Lim, Kim, Hyung-Kee, Huh, Seung, Won, Dong Il, Kim, Chan-Duck
Формат: Artigo
Язык:Inglês
Опубликовано: The Korean Academy of Medical Sciences 2020
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7308135/
https://ncbi.nlm.nih.gov/pubmed/32567256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2020.35.e185
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы